课题基金 / 基金详情

TRANSFORMATION BY ABELSON MURINE LEUKEMIA VIRUS

TRANSFORMATION BY ABELSON MURINE LEUKEMIA VIRUS
阿贝尔森鼠白血病病毒的转化
批准号:
3167664
负责人:
OWEN N. WITTE
金额:
$11.99万
依托单位国家:
美国
项目类别:
财政年份:
1980
资助国家:
美国
项目状态:
已结题
起止时间:
1980-05-01 至 1986-04-30

项目摘要

项目成果

OWEN N. WITTE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal will investigate the molecular mechanisms involved in the abnormal growth regulation of murine lymphocytes transformed by the Abelson murine leukemia virus (A-MuLV). A detailed evaluation of the genetic and enzymatic properties of the A-MuLV transforming gene and its normal cellular homolog will be carried out. Preparation of improved serological and kinase substrate reagents will be done using synthetic peptide technology. Both wild type and mutants including partial or complete transformation defective strains, non-lethal variants, and temperature sensitive strains will be used to study the interaction of the viral phosphotyrosine kinase with the host cell environment. The temporal process and phenotypic progression of normal B lymphoid cells post-infection with A-MuLV towards the transformed state will be followed using newly developed cell culture techniques (Whitlock and Witte, 1982a). These studies will better define the nature of the A-MuLV target cell and cellular factors required for full expression of the transformed state in lymphoid cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MICRO/NANO-IMMUNOCHIP (UIC) DEVELOPMENT AND TESTING IN MICE AND HUMANS
Developmental Research Program
Evaluating a Novel Strategy to Target Trop2 in Prostate Cancer
Project 3: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
海外基金